Preclinical assessment of iodantipyrine safety

A. S. Saratikov, T. P. Novozheeva, N. S. Livshits, F. I. Burchenkova, N. G. Kadychagova, R. R. Akhmedzhanov, L. V. Bashirova, A. A. Eremina, G. V. Potapova

Research output: Contribution to journalArticle

Abstract

Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

Original languageEnglish
Number of pages1
JournalEksperimental'naya i Klinicheskaya Farmakologiya
Volume61
Issue number2
Publication statusPublished - 1 Jan 1998

Fingerprint

Poisons
Lethal Dose 50
Antiviral Agents
Rats
Dogs
Safety
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Saratikov, A. S., Novozheeva, T. P., Livshits, N. S., Burchenkova, F. I., Kadychagova, N. G., Akhmedzhanov, R. R., ... Potapova, G. V. (1998). Preclinical assessment of iodantipyrine safety. Eksperimental'naya i Klinicheskaya Farmakologiya, 61(2).

Preclinical assessment of iodantipyrine safety. / Saratikov, A. S.; Novozheeva, T. P.; Livshits, N. S.; Burchenkova, F. I.; Kadychagova, N. G.; Akhmedzhanov, R. R.; Bashirova, L. V.; Eremina, A. A.; Potapova, G. V.

In: Eksperimental'naya i Klinicheskaya Farmakologiya, Vol. 61, No. 2, 01.01.1998.

Research output: Contribution to journalArticle

Saratikov, AS, Novozheeva, TP, Livshits, NS, Burchenkova, FI, Kadychagova, NG, Akhmedzhanov, RR, Bashirova, LV, Eremina, AA & Potapova, GV 1998, 'Preclinical assessment of iodantipyrine safety', Eksperimental'naya i Klinicheskaya Farmakologiya, vol. 61, no. 2.
Saratikov AS, Novozheeva TP, Livshits NS, Burchenkova FI, Kadychagova NG, Akhmedzhanov RR et al. Preclinical assessment of iodantipyrine safety. Eksperimental'naya i Klinicheskaya Farmakologiya. 1998 Jan 1;61(2).
Saratikov, A. S. ; Novozheeva, T. P. ; Livshits, N. S. ; Burchenkova, F. I. ; Kadychagova, N. G. ; Akhmedzhanov, R. R. ; Bashirova, L. V. ; Eremina, A. A. ; Potapova, G. V. / Preclinical assessment of iodantipyrine safety. In: Eksperimental'naya i Klinicheskaya Farmakologiya. 1998 ; Vol. 61, No. 2.
@article{57376dd88ec044c5a66e3688512f599c,
title = "Preclinical assessment of iodantipyrine safety",
abstract = "Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.",
author = "Saratikov, {A. S.} and Novozheeva, {T. P.} and Livshits, {N. S.} and Burchenkova, {F. I.} and Kadychagova, {N. G.} and Akhmedzhanov, {R. R.} and Bashirova, {L. V.} and Eremina, {A. A.} and Potapova, {G. V.}",
year = "1998",
month = "1",
day = "1",
language = "English",
volume = "61",
journal = "Eksperimental'naya i Klinicheskaya Farmakologiya",
issn = "0869-2092",
publisher = "Izdatelstvo Meditsina",
number = "2",

}

TY - JOUR

T1 - Preclinical assessment of iodantipyrine safety

AU - Saratikov, A. S.

AU - Novozheeva, T. P.

AU - Livshits, N. S.

AU - Burchenkova, F. I.

AU - Kadychagova, N. G.

AU - Akhmedzhanov, R. R.

AU - Bashirova, L. V.

AU - Eremina, A. A.

AU - Potapova, G. V.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

AB - Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

UR - http://www.scopus.com/inward/record.url?scp=0347718487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347718487&partnerID=8YFLogxK

M3 - Article

VL - 61

JO - Eksperimental'naya i Klinicheskaya Farmakologiya

JF - Eksperimental'naya i Klinicheskaya Farmakologiya

SN - 0869-2092

IS - 2

ER -